{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T03:12:10Z","timestamp":1772334730500,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ajog.2013.11.001","type":"journal-article","created":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T22:07:44Z","timestamp":1383862064000},"page":"255.e1-255.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma"],"prefix":"10.1016","volume":"210","author":[{"given":"Rashmi","family":"Kudesia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomer","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin Michael","family":"Holcomb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac","family":"Kligman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zev","family":"Rosenwaks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2013.11.001_bib1","unstructured":"National Cancer Institute. Surveillance Epidemiology and End Results. Available at: http:\/\/seer.cancer.gov\/statistics\/. Accessed May 15,\u00a02012."},{"key":"10.1016\/j.ajog.2013.11.001_bib2","unstructured":"National Cancer Institute. Cancer Trends Progress Report\u20142011\/2012 Update. Bethesda, MD: National Institutes of Health, Department of\u00a0Health and Human Services;\u00a02012."},{"key":"10.1016\/j.ajog.2013.11.001_bib3","unstructured":"Sherry B, Blanck HM, Galuska DA, Pan L, Dietz WH, Balluz L. MMWR: vital signs: state-specific obesity prevalence among adults\u2014United States, 2009. Atlanta, GA: Centers for Disease Control and Prevention;\u00a02010."},{"key":"10.1016\/j.ajog.2013.11.001_bib4","series-title":"Delayed childbearing: more women are having their first child later in life. NCHS data brief, number 21","author":"Mathews","year":"2009"},{"key":"10.1016\/j.ajog.2013.11.001_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ygyno.2003.08.007","article-title":"Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and\/or complex hyperplasia with atypia","volume":"91","author":"Lowe","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2013.11.001_bib6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/annonc\/mdq463","article-title":"Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women","volume":"22","author":"Minig","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ajog.2013.11.001_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1471-0528.2008.02024.x","article-title":"Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases","volume":"116","author":"Signorelli","year":"2009","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2013.11.001_bib8","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2013.11.001_bib9","first-page":"718","article-title":"Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer","volume":"102","author":"Gotlieb","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.11.001_bib10","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/IGC.0b013e3181aae1fb","article-title":"Conservative treatment with progestin and pregnancy outcomes in endometrial cancer","volume":"19","author":"Hahn","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2013.11.001_bib11","doi-asserted-by":"crossref","first-page":"266.e1","DOI":"10.1016\/j.ajog.2012.08.011","article-title":"Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis","volume":"207","author":"Gallos","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.11.001_bib12","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/AOG.0b013e31828d6186","article-title":"Systemic and local hormone therapy for endometrial hyperplasia and early adenocarcinoma","volume":"121","author":"Hubbs","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.11.001_bib13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/09513590902733733","article-title":"The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option","volume":"25","author":"Gadducci","year":"2009","journal-title":"Gynecol Endocrinol"},{"issue":"Suppl 2","key":"10.1016\/j.ajog.2013.11.001_bib14","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.ygyno.2008.07.056","article-title":"Sparing fertility in young patients with endometrial cancer","volume":"111","author":"Chiva","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2013.11.001_bib15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ygyno.2009.08.011","article-title":"A\u00a0review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer","volume":"115","author":"Zivanovic","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2013.11.001_bib16","first-page":"477","article-title":"Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review","volume":"125","author":"Ramirez","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2013.11.001_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2013.11.001_bib18","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ygyno.2011.11.004","article-title":"Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy","volume":"124","author":"Penner","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2013.11.001_bib19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ygyno.2011.11.043","article-title":"Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature","volume":"125","author":"Baker","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2013.11.001_bib20","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Trimble","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2013.11.001_bib21","series-title":"American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2010 assisted reproductive technology fertility clinic success rates report","year":"2012"},{"key":"10.1016\/j.ajog.2013.11.001_bib22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.AOG.0000172423.64995.6f","article-title":"Coexisting ovarian malignancy in young women with endometrial cancer","volume":"106","author":"Walsh","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.11.001_bib23","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.fertnstert.2012.09.022","article-title":"Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer","volume":"98","author":"Reddy","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2013.11.001_bib24","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1200\/JCO.2008.19.8150","article-title":"Safety of ovarian preservation in premenopausal women with endometrial cancer","volume":"27","author":"Wright","year":"2009","journal-title":"J\u00a0Clin Oncol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937813019959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937813019959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:57:21Z","timestamp":1757588241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937813019959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0002937813019959"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2013.11.001","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2013.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}